64x Bio

64x Bio offers an end-to-end platform designed to facilitate the development and manufacturing of next-generation biologics. Central to their approach is the VectorSelect technology, which aims to address the challenges of scaling therapeutic systems. The company focuses on the intersection of advanced therapeutics and scalable bioengineering, providing solutions that enhance the efficiency and yield of cell line development and biologic manufacturing processes. By combining massively parallelized screening with computational insights, 64x Bio accelerates the production of advanced therapies,…